10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
Has downside compared to CGAU's upside of 39.95%.
Buy
Equal to CGAU's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
3.98M
The estimated revenue has increased from the previous period.
1.66M
The estimated EBITDA has increased from the previous period.
-0.12
The estimated EPS has decreased from the previous period.
-38.60M
The estimated net income has decreased from the previous period.
1.50M
The estimated EBIT has increased from the previous period.
3.56M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
246.45M
Revenue has increased from the previous period.
44.55%
Revenue growth rate has increased from the previous period.
160.33M
EBITDA has increased from the previous period.
65.06%
EBITDA margin has increased from the previous period.
130.88M
EBIT has increased from the previous period.
53.11%
EBIT margin has increased from the previous period.
29.44M
Depreciation has increased from the previous period.
115.26M
Total cash has increased from the previous period.
46.77%
Cash percentage has increased from the previous period.
6.24M
Receivables have decreased from the previous period.
2.53%
Receivables percentage has decreased from the previous period.
20.93M
Inventories have decreased from the previous period.
8.49%
Inventory percentage has decreased from the previous period.
8.13M
Accounts payable has increased from the previous period.
3.30%
Payables percentage has decreased from the previous period.
-21.09M
Capital expenditure has increased from the previous period.
-8.56%
CapEx percentage has decreased from the previous period.
9.14%
WACC has increased from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
66.07M
EBIAT has increased from the previous period.
80.84M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.66M
Enterprise value has decreased from the previous period.
-113.70M
Net debt is unchanged from the previous period.
187.36M
Equity value has decreased from the previous period.
0.56
Equity value per share has decreased from the previous period.
